Series A funding round for Kenai Therapeutics raising $82M in February 2024
Series A funding round for Kenai Therapeutics raising $82M in February 2024
| Investor | Firm Type | Partner |
|---|
Cure VenturesLEAD | Venture Capital | — |
| Venture Capital | — | |
The Column GroupLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$86M
Top Valuation
-
Kenai Therapeutics raised $82M in a Series A round.
The round was announced on 02/01/24.
The round was led by Cure Ventures, The Column Group, Alaska Permanent Fund.